Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction
- 25 September 1990
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (9), C9-C20
- https://doi.org/10.1016/0002-9149(90)90757-r
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Incidence and Prognosis of Unrecognized Myocardial InfarctionNew England Journal of Medicine, 1984
- The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.Circulation, 1984
- Analysis of ambulatory electrocardiograms in 15 patients during spontaneous ventricular fibrillation with special reference to preceding arrhythmic eventsJournal of the American College of Cardiology, 1983
- Effect of antiarrhythmic drugs on mortality after myocardial infarctionThe American Journal of Cardiology, 1983
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981
- Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction.Circulation, 1979
- Sudden cardiac death: The major challenge confronting contemporary cardiologyThe American Journal of Cardiology, 1979
- Ventricular Premature Beats and Mortality after Myocardial InfarctionNew England Journal of Medicine, 1977